why choose us

First received: January 12, 2023

Clinical Trial: DZD9008 in Pretreated Lung Cancer Patients With EGFR Exon20 Insertion Mutation

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Non-Small Cell Lung Cancer

Study Type: Interventional


Official Title: A Phase II, Single Arm, Multicenter Study to Evaluate Anti-tumor Activity, Safety, Tolerability and Pharmacokinetics of DZD9008 in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Wit

Brief Summary: This is a Phase II, single-arm, multi-center clinical study to evaluate the anti-tumor efficacy, safety, tolerability and pharmacokinetics of DZD9008 in participants with locally advanced or metastatic NSCLC carrying EGFR exon 20 insertion mutations whose disease has progressed on prior platinum-based chemotherapy

Read more